pharmacokinetic blood and dialysate sampling

PROCEDURE2 trials

Sponsors

University of Michigan

Conditions

Cardiovascular DiseaseCritically Ill Renal Failure Requiring CVVHD and OseltamivirCritically Ill Requiring ECMO and OseltamivirEnd-stage Renal Disease

Phase 4

Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)

CompletedNCT01048879

University of MichiganCritically Ill Renal Failure Requiring CVVHD and Oseltamivir, Critically Ill Requiring ECMO and Oseltamivir

Start: 2009-10-31End: 2010-01-31Updated: 2012-08-21

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients

CompletedNCT01435174

University of MichiganCardiovascular Disease, End-stage Renal Disease

Start: 2011-10-31End: 2013-03-31Updated: 2017-10-16

Related Papers

Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.

2019-11-012 citations